Business Desk, Amar Ujala, New Delhi
Published by: Deepak Chaturvedi
Updated to Thursday, 16 December 2021 10:13 AM IST
Supriya LifeScience IPO: If you are thinking of investing, you have a great opportunity today. In fact, Supriya Life Sciences’ maker of active pharmaceuticals ingredient Supriya has launched an initial public offering (IPO) on Thursday for investment. The company plans to raise Rs 700 crore through this IPO.
Listen to the news
The price band was kept that way
The company has set a price target of Rs 265 to Rs 274 per share for the Supriya LifeScience IPO. This upper price band is trading in the gray market with a premium of 91%. Of this, Rs. 500 crore along with an offer of Rs. 200 crore worth of shares were also issued. The promoter owns 99.98 per cent equity stake in Supriya Life Sciences. Supriya Life Sciences is in strong demand in the gray market. Issue price Rs. It is priced at Rs. 250 or Rs. 524.
The very size of the shares is here
In this IPO, let you know that investors can bid for at least 54 equity shares and then multiply by 54 shares. Retail investors can bid for a minimum of Rs 14,796 per lot and bid up to Rs. Their maximum investment is Rs 1,92,348 for 13 lots as they are allowed to invest up to Rs 2 lakh. Of this, 75 per cent was earmarked for eligible institutional buyers, 10 per cent for retail investors and the remaining 15 per cent for non-institutional investors.
The amount collected will be spent here
The company said the money raised through the IPO will be used for general corporate purposes as well as capital expenditure requirements and loan repayments. The company in particular is making pharma products. It has a product line of 38 Active Pharmaceuticals Ingredients (APIs) focused on therapeutics such as antihistamines, analgesics, narcotics, vitamins, anti asthma and antiallergic.